SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622
http://www.w3.org/2000/01/rdf-schema#comment
"The simultaneous action of PDGF-B/PDGFRbeta and VEGF165b on the same type of receptor may explain the resistance to antiangiogenic therapy which depends on the degree of modulation of PDGFRbeta phosphorylation."
xsd:string
http://purl.uniprot.org/uniprot/#_6665E2AA8A2C45F15F6B52AA502A9E60A1EB47BBCC11E5FF016986DFADCA8A9FD1EFDD1A2D7C45692F99B4800CADB0D4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622
http://purl.uniprot.org/uniprot/Q9UE57
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622
http://purl.uniprot.org/uniprot/#_Q9UE57-mappedCitation-27127135
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/59339A3AE34A650CE50C43EE718A89D357751ED4615DA5AA787626C6602BA2F1883ADC6E327D7FB5FEA4BB958D6FE622